Tag Archives: washington dc arthritis advocacy

Washington DC Arthritis Advocacy Victory

The Nation’s Capital Caps the Out-of-Pocket Costs of Medications

Congratulations D.C. Advocates! Because of your efforts, Washington, D.C. Mayor Muriel Bowser signed the Specialty Drug Copayment Limitation Act. In the law, “specialty drug” means a prescription drug that is prescribed for a person with a physical, behavioral, or developmental condition that may have no known cure, is progressive, or can be debilitating or fatal if left untreated or undertreated, such as multiple sclerosis, hepatitis C and rheumatoid arthritis.
Continue reading The Nation’s Capital Caps the Out-of-Pocket Costs of Medications